About this Journal Submit a Manuscript Table of Contents
Stem Cells International
Volume 2013 (2013), Article ID 132642, 8 pages
http://dx.doi.org/10.1155/2013/132642
Review Article

Bone-Marrow-Derived Mesenchymal Stem Cells for Organ Repair

Department of Stem Cell Disorders, Kansai Medical University, Moriguchi, Osaka 570-8506, Japan

Received 5 October 2012; Accepted 28 January 2013

Academic Editor: Rangnath Mishra

Copyright © 2013 Ming Li and Susumu Ikehara. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Bi, R. Schmitt, M. Israilova, H. Nishio, and L. G. Cantley, “Stromal cells protect against acute tubular injury via an endocrine effect,” Journal of the American Society of Nephrology, vol. 18, no. 9, pp. 2486–2496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. Friedenstein, R. K. Chailakhjan, and K. S. Lalykina, “The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells,” Cell and Tissue Kinetics, vol. 3, no. 4, pp. 393–403, 1970. View at Scopus
  3. A. J. Friedenstein, R. K. Chailakhyan, and N. V. Latsinik, “Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo,” Transplantation, vol. 17, no. 4, pp. 331–340, 1974. View at Scopus
  4. A. I. Caplan, “Mesenchymal stem cells,” Journal of Orthopaedic Research, vol. 9, no. 5, pp. 641–650, 1991. View at Scopus
  5. M. D. Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Raffaghello, G. Bianchi, M. Bertolotto et al., “Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche,” Stem Cells, vol. 26, no. 1, pp. 151–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Aggarwal and M. F. Pittenger, “Human mesenchymal stem cells modulate allogeneic immune cell responses,” Blood, vol. 105, no. 4, pp. 1815–1822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. T. Williams, S. S. Southerland, J. Souza, A. F. Calcutt, and R. G. Cartledge, “Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes,” American Surgeon, vol. 65, no. 1, pp. 22–26, 1999. View at Scopus
  9. P. A. Zuk, M. Zhu, H. Mizuno et al., “Multilineage cells from human adipose tissue: implications for cell-based therapies,” Tissue Engineering, vol. 7, no. 2, pp. 211–228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Erices, P. Conget, and J. J. Minguell, “Mesenchymal progenitor cells in human umbilical cord blood,” British Journal of Haematology, vol. 109, no. 1, pp. 235–242, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. C. De Bari, F. Dell'Accio, P. Tylzanowski, and F. P. Luyten, “Multipotent mesenchymal stem cells from adult human synovial membrane,” Arthritis & Rheumatism, vol. 44, no. 8, pp. 1928–1942, 2001.
  12. S. A. Kuznetsov, M. H. Mankani, S. Gronthos, K. Satomura, P. Bianco, and P. G. Robey, “Circulating skeletal stem cells,” Journal of Cell Biology, vol. 153, no. 5, pp. 1133–1139, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Gronthos, M. Mankani, J. Brahim, P. G. Robey, and S. Shi, “Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 25, pp. 13625–13630, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. P. S. In 't Anker, S. A. Scherjon, C. Kleijburg-van der Keur et al., “Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation,” Blood, vol. 102, no. 4, pp. 1548–1549, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. W. A. Noort, A. B. Kruisselbrink, P. S. In't Anker et al., “Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice,” Experimental Hematology, vol. 30, no. 8, pp. 870–878, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. C. G. Fan, F. W. Tang, Q. J. Zhang et al., “Characterization and neural differentiation of fetal lung mesenchymal stem cells,” Cell Transplantation, vol. 14, no. 5, pp. 311–321, 2005. View at Scopus
  17. C. Campagnoli, I. A. G. Roberts, S. Kumar, P. R. Bennett, I. Bellantuono, and N. M. Fisk, “Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow,” Blood, vol. 98, no. 8, pp. 2396–2402, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Makino, K. Fukuda, S. Miyoshi et al., “Cardiomyocytes can be generated from marrow stromal cells in vitro,” Journal of Clinical Investigation, vol. 103, no. 5, pp. 697–705, 1999. View at Scopus
  20. L. A. Ortiz, F. Gambelli, C. McBride et al., “Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8407–8411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Arnhold, Y. Absenger, H. Klein, K. Addicks, and U. Schraermeyer, “Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 245, no. 3, pp. 414–422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Nakagawa, S. Akita, M. Fukui, T. Fujii, and K. Akino, “Human mesenchymal stem cells successfully improve skin-substitute wound healing,” British Journal of Dermatology, vol. 153, no. 1, pp. 29–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Fu, L. Fang, X. Li, B. Cheng, and Z. Sheng, “Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury,” Wound Repair and Regeneration, vol. 14, no. 3, pp. 325–335, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Morigi, B. Imberti, C. Zoja et al., “Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure,” Journal of the American Society of Nephrology, vol. 15, no. 7, pp. 1794–1804, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. G. C. Kopen, D. J. Prockop, and D. G. Phinney, “Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 19, pp. 10711–10716, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Muñoz-Elias, A. J. Marcus, T. M. Coyne, D. Woodbury, and I. B. Black, “Adult bone marrow stromal cells in the embryonic brain: engraftment, migration, differentiation, and long-term survival,” Journal of Neuroscience, vol. 24, no. 19, pp. 4585–4595, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. E. Schwartz, M. Reyes, L. Koodie et al., “Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells,” Journal of Clinical Investigation, vol. 109, no. 10, pp. 1291–1302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Q. Tang, L. Z. Cao, B. R. Burkhardt et al., “In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow,” Diabetes, vol. 53, no. 7, pp. 1721–1732, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Peister, J. A. Mellad, B. L. Larson, B. M. Hall, L. F. Gibson, and D. J. Prockop, “Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential,” Blood, vol. 103, no. 5, pp. 1662–1668, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Beyth, Z. Borovsky, D. Mevorach et al., “Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness,” Blood, vol. 105, no. 5, pp. 2214–2219, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Ramasamy, H. Fazekasova, E. W. F. Lam, I. Soeiro, G. Lombardi, and F. Dazzi, “Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle,” Transplantation, vol. 83, no. 1, pp. 71–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Zhang, R. Liu, D. Shi et al., “Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2 dependent regulatory dendritic cell population,” Blood, vol. 113, no. 1, pp. 46–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Aldinucci, L. Rizzetto, L. Pieri et al., “Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation,” Journal of Immunology, vol. 185, no. 9, pp. 5102–5110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Uccelli, L. Moretta, and V. Pistoia, “Mesenchymal stem cells in health and disease,” Nature Reviews Immunology, vol. 8, no. 9, pp. 726–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. P. A. Sotiropoulou, S. A. Perez, A. D. Gritzapis, C. N. Baxevanis, and M. Papamichail, “Interactions between human mesenchymal stem cells and natural killer cells,” Stem Cells, vol. 24, no. 1, pp. 74–85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. G. M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M. C. Mingari, and L. Moretta, “Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2,” Blood, vol. 111, no. 3, pp. 1327–1333, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. A. Potian, H. Aviv, N. M. Ponzio, J. S. Harrison, and P. Rameshwar, “Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens,” Journal of Immunology, vol. 171, no. 7, pp. 3426–3434, 2003. View at Scopus
  38. W. Zhang, W. Ge, C. Li et al., “Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells,” Stem Cells and Development, vol. 13, no. 3, pp. 263–271, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Corcione, F. Benvenuto, E. Ferretti et al., “Human mesenchymal stem cells modulate B-cell functions,” Blood, vol. 107, no. 1, pp. 367–372, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. J. Nauta, G. Westerhuis, A. B. Kruisselbrink, E. G. A. Lurvink, R. Willemze, and W. E. Fibbe, “Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting,” Blood, vol. 108, no. 6, pp. 2114–2120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Zhang, Y. Li, J. Chen et al., “Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice,” Experimental Neurology, vol. 195, no. 1, pp. 16–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. S. M. Devine, A. M. Bartholomew, N. Mahmud et al., “Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion,” Experimental Hematology, vol. 29, no. 2, pp. 244–255, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. R. F. Wynn, C. A. Hart, C. Corradi-Perini et al., “A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow,” Blood, vol. 104, no. 9, pp. 2643–2645, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. M. B. Herrera, B. Bussolati, S. Bruno et al., “Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury,” Kidney International, vol. 72, no. 4, pp. 430–441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Chapel, J. M. Bertho, M. Bensidhoum et al., “Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome,” Journal of Gene Medicine, vol. 5, no. 12, pp. 1028–1038, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Mahmood, D. Lu, M. Lu et al., “Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells,” Neurosurgery, vol. 53, no. 3, pp. 697–703, 2003. View at Scopus
  47. D. Orlic, J. Kajstura, S. Chimenti et al., “Mobilized bone marrow cells repair the infarcted heart, improving function and survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10344–10349, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. J. M. Fox, G. Chamberlain, B. A. Ashton, and J. Middleton, “Recent advances into the understanding of mesenchymal stem cell trafficking,” British Journal of Haematology, vol. 137, no. 6, pp. 491–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. A. L. Ponte, E. Marais, N. Gallay et al., “The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities,” Stem Cells, vol. 25, no. 7, pp. 1737–1745, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. D. G. Phinney and D. J. Prockop, “Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views,” Stem Cells, vol. 25, no. 11, pp. 2896–2902, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Poloni, G. Maurizi, P. Leoni, et al., “Human dedifferentiated adipocytes show similar properties to bone marrow-derived mesenchymal stem cells,” Stem Cells, vol. 30, no. 5, pp. 965–974, 2012. View at Publisher · View at Google Scholar
  52. J. M. Gimble, A. J. Katz, and B. A. Bunnell, “Adipose-derived stem cells for regenerative medicine,” Circulation Research, vol. 100, no. 9, pp. 1249–1260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. L. A. Ortiz, M. DuTreil, C. Fattman et al., “Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 11002–11007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Pati, M. H. Gerber, T. D. Menge, et al., “Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock,” PLoS One, vol. 6, no. 9, Article ID e25171, 2011.
  55. G. F. Curley, M. Hayes, B. Ansari, et al., “Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat,” Thorax, vol. 67, no. 6, pp. 496–501, 2012. View at Publisher · View at Google Scholar
  56. U. Kunter, S. Rong, Z. Djuric et al., “Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis,” Journal of the American Society of Nephrology, vol. 17, no. 8, pp. 2202–2212, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Alfarano, C. Roubeix, R. Chaaya, et al., “Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats,” Cell Transplant, vol. 21, no. 9, pp. 2009–2019, 2012. View at Publisher · View at Google Scholar
  58. R. H. Lee, M. J. Seo, R. L. Reger et al., “Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 46, pp. 17438–17443, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Si, Y. Zhao, H. Hao, et al., “Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity,” Diabetes, vol. 61, no. 6, pp. 1616–1625, 2012.
  60. Y. Iso, J. L. Spees, C. Serrano et al., “Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment,” Biochemical and Biophysical Research Communications, vol. 354, no. 3, pp. 700–706, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Cho, P. Zhai, Y. Maejima, and J. Sadoshima, “Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction,” Circulation Research, vol. 108, no. 4, pp. 478–489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Kanazawa, Y. Fujimoto, T. Teratani et al., “Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model,” PLoS ONE, vol. 6, no. 4, Article ID e19195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. W. Zhao, J. J. Li, D. Y. Cao, et al., “Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis,” World Journal of Gastroenterology, vol. 18, no. 10, pp. 1048–1058, 2012.
  64. M. A. Edalatmanesh, A. R. Bahrami, E. Hosseini, M. Hosseini, and S. Khatamsaz, “Bone marrow derived mesenchymal stem cell transplantation in cerebellar degeneration: a behavioral study,” Behavioural Brain Research, vol. 225, no. 1, pp. 63–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. N. C. Kaneider, A. J. Leger, and A. Kuliopulos, “Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions,” FEBS Journal, vol. 273, no. 19, pp. 4416–4424, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Kolb, P. J. Margetts, D. C. Anthony, F. Pitossi, and J. Gauldie, “Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis,” Journal of Clinical Investigation, vol. 107, no. 12, pp. 1529–1536, 2001. View at Scopus
  67. F. Anglani, M. Forino, D. Del Prete, E. Tosetto, R. Torregrossa, and A. D'Angelo, “In search of adult renal stem cells,” Journal of Cellular and Molecular Medicine, vol. 8, no. 4, pp. 474–487, 2004. View at Scopus
  68. C. Lange, F. Tögel, H. Ittrich et al., “Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats,” Kidney International, vol. 68, no. 4, pp. 1613–1617, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. V. S. Urbán, J. Kiss, J. Kovács et al., “Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes,” Stem Cells, vol. 26, no. 1, pp. 244–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. Z. H. Liu, J. S. Peng, C. J. Li et al., “A simple taurocholate-induced model of severe acute pancreatitis in rats,” World Journal of Gastroenterology, vol. 15, no. 45, pp. 5732–5739, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. X. H. Tu, J. X. Song, X. J. Xue, et al., “Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis,” World Journal of Gastroenterology, vol. 18, no. 18, pp. 2270–2279, 2012.
  72. C. Moriscot, F. De Fraipont, M. J. Richard et al., “Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro,” Stem Cells, vol. 23, no. 4, pp. 594–603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Zhao, S. A. Amiel, S. Ajami et al., “Amelioration of streptozotocin-induced diabetes in mice with cells derived from human marrow stromal cells,” PLoS ONE, vol. 3, no. 7, Article ID e2666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Y. Yeung, K. L. Seeberger, T. Kin, et al., “Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines,” PLoS One, vol. 7, no. 5, Article ID e38189, 2012.
  75. K. H. Jung, S. U. Song, T. Yi et al., “Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats,” Gastroenterology, vol. 140, no. 3, pp. 998–1008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Mazo, B. Pelacho, and F. Prósper, “Stem cell therapy for chronic myocardial infarction,” Journal of Cardiovascular Translational Research, vol. 3, no. 2, pp. 79–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Wakitani, T. Saito, and A. I. Caplan, “Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine,” Muscle and Nerve, vol. 18, no. 12, pp. 1417–1426, 1995. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Li, S. Zhang, Y. Zhang, B. Yu, Y. Xu, and Z. Guan, “Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure,” Molecular Biology Reports, vol. 36, no. 4, pp. 725–731, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Ohnishi, H. Sumiyoshi, S. Kitamura, and N. Nagaya, “Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions,” FEBS Letters, vol. 581, no. 21, pp. 3961–3966, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. C. Mias, O. Lairez, E. Trouche et al., “Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction,” Stem Cells, vol. 27, no. 11, pp. 2734–2743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. H. C. Quevedo, K. E. Hatzistergos, B. N. Oskouei et al., “Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 33, pp. 14022–14027, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. H. P. Zhou, D. H. Yi, S. Q. Yu et al., “Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft,” Transplantation Proceedings, vol. 38, no. 9, pp. 3046–3051, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. I. M. Barbash, P. Chouraqui, J. Baron et al., “Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution,” Circulation, vol. 108, no. 7, pp. 863–868, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. W. Sherman, T. P. Martens, J. F. Viles-Gonzalez, and T. Siminiak, “Catheter-based delivery of cells to the heart,” Nature Clinical Practice Cardiovascular Medicine, vol. 3, supplement 1, pp. S57–S64, 2006.
  85. L. C. Amado, A. P. Saliaris, K. H. Schuleri et al., “Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 32, pp. 11474–11479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. K. H. Schuleri, L. C. Amado, A. J. Boyle et al., “Early improvement in cardiac tissue perfusion due to mesenchymal stem cells,” American Journal of Physiology, vol. 294, no. 5, pp. H2002–H2011, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. S. L. Chen, W. W. Fang, F. Ye et al., “Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction,” American Journal of Cardiology, vol. 94, no. 1, pp. 92–95, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. A. R. Williams, B. Trachtenberg, D. L. Velazquez et al., “Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling,” Circulation Research, vol. 108, no. 7, pp. 792–796, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. D. A. Rappolee, C. Basilico, Y. Patel, and Z. Werb, “Expression and function of FGF-4 in peri-implantation development in mouse embryos,” Development, vol. 120, no. 8, pp. 2259–2269, 1994. View at Scopus
  90. C. Schmidt, F. Bladt, S. Goedecke et al., “Scatter factor/hepatocyte growth factor is essential for liver development,” Nature, vol. 373, no. 6516, pp. 699–702, 1995. View at Scopus
  91. A. Miyajima, T. Kinoshita, M. Tanaka, A. Kamiya, Y. Mukouyama, and T. Hara, “Role of oncostatin M in hematopoiesis and liver development,” Cytokine and Growth Factor Reviews, vol. 11, no. 3, pp. 177–183, 2000. View at Publisher · View at Google Scholar · View at Scopus
  92. X. J. Dong, H. Zhang, R. L. Pan, L. X. Xiang, and J. Z. Shao, “Identification of cytokines involved in hepatic differentiation of mBM-MSCs under liver-injury conditions,” World Journal of Gastroenterology, vol. 16, no. 26, pp. 3267–3278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. S. P. Lam, J. M. Luk, K. Man et al., “Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration,” Liver Transplantation, vol. 16, no. 10, pp. 1195–1206, 2010. View at Scopus
  94. R. Bataller and D. A. Brenner, “Liver fibrosis,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 209–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. D. S. Lee, W. H. Gil, H. H. Lee et al., “Factors affecting graft survival after living donor liver transplantation,” Transplantation Proceedings, vol. 36, no. 8, pp. 2255–2256, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. D. C. Zhao, J. X. Lei, R. Chen et al., “Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats,” World Journal of Gastroenterology, vol. 11, no. 22, pp. 3431–3440, 2005. View at Scopus
  97. A. M. Parr, C. H. Tator, and A. Keating, “Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury,” Bone Marrow Transplantation, vol. 40, no. 7, pp. 609–619, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Wang, F. Ding, Y. Gu, J. Liu, and X. Gu, “Bone marrow mesenchymal stem cells promote cell proliferation and neurotrophic function of Schwann cells in vitro and in vivo,” Brain Research, vol. 1262, pp. 7–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. S. P. Wang, Z. H. Wang, D. Y. Peng, S. M. Li, H. Wang, and X. H. Wang, “Therapeutic effect of mesenchymal stem cells in rats with intracerebral hemorrhage: reduced apoptosis and enhanced neuroprotection,” Molecular Medicine Reports, vol. 6, no. 4, pp. 848–854, 2012.
  100. A. Uccelli, E. Zappia, F. Benvenuto, F. Frassoni, and G. Mancardi, “Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection,” Expert Opinion on Biological Therapy, vol. 6, no. 1, pp. 17–22, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. K. Kurozumi, K. Nakamura, T. Tamiya et al., “BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model,” Molecular Therapy, vol. 9, no. 2, pp. 189–197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. N. K. Venkataramana, R. Pal, S. A. Rao, et al., “Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: a pilot clinical study,” Stem Cells International, vol. 2012, Article ID 931902, 12 pages, 2012. View at Publisher · View at Google Scholar
  103. D. K. Podolsky, “Inflammatory bowel disease,” The New England Journal of Medicine, vol. 347, no. 6, pp. 417–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. M. T. Castelo-Branco, I. D. Soares, D. V. Lopes, et al., “Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis,” PLoS One, vol. 7, no. 3, Article ID e33360, 2012.
  105. Y. Ando, M. Inaba, Y. Sakaguchi et al., “Subcutaneous adipose tissue-derived stem cells facilitate colonic mucosal recovery from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats,” Inflammatory Bowel Diseases, vol. 14, no. 6, pp. 826–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. H. Jiang, L. Qu, Y. Li et al., “Bone marrow mesenchymal stem cells reduce intestinal ischemia/reperfusion injuries in rats,” Journal of Surgical Research, vol. 168, no. 1, pp. 127–134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  107. E. Zomorodian and M. B. Eslaminejad, “Mesenchymal stem cells as a potent cell source for bone regeneration,” Stem Cells International, vol. 2012, Article ID 980353, 9 pages, 2012. View at Publisher · View at Google Scholar
  108. F. Granero-Moltó, J. A. Weis, M. I. Miga et al., “Regenerative effects of transplanted mesenchymal stem cells in fracture healing,” Stem Cells, vol. 27, no. 8, pp. 1887–1898, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. E. M. Horwitz, P. L. Gordon, W. K. K. Koo et al., “Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 8932–8937, 2002. View at Publisher · View at Google Scholar · View at Scopus